PXN and breast carcinoma: More recently, DLX6-AS1 (a long noncoding RNA that adsorbs miRNA-199b) promoted epithelial–mesenchymal transition and cisplatin resistance via the miR-199b-5p/PXN axis in breast cancer cells [50].